Parathyroidectomy Versus Cinacalcet for the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients

BACKGROUND: Secondary hyperparathyroidism in patients with end stage renal disease on dialysis is associated with bone pain and fractures in addition to cardiovascular morbidity. Cinacalcet is the most commonly used drug to treat such patients, but it has never been compared to surgery. The goal of...

Descripción completa

Detalles Bibliográficos
Autores principales: Alvarado, Luis, Sharma, Nishtha, Lerma, Roxann, Dwivedi, Alok, Ahmad, Adeel, Hechanova, Aimee, Payan-Schober, Fernanda, Nwosu, Azikiwe, Alkhalili, Eyas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Scientific Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885484/
https://www.ncbi.nlm.nih.gov/pubmed/35022799
http://dx.doi.org/10.1007/s00268-022-06439-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885484/
https://www.ncbi.nlm.nih.gov/pubmed/35022799
http://dx.doi.org/10.1007/s00268-022-06439-7

Ejemplares similares